Variant report
Variant | nsv962096 |
---|---|
Chromosome Location | chr2:211238120-211250354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557721997 | chr2:211238126-211238127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4338912 | chr2:211238151-211238152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs113971975 | chr2:211238154-211238155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184197942 | chr2:211238165-211238166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13023699 | chr2:211238204-211238205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs13000495 | chr2:211238213-211238214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13000502 | chr2:211238217-211238218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572857328 | chr2:211238229-211238230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1350464 | chr2:211238290-211238291 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs375523382 | chr2:211238294-211238295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574926204 | chr2:211238303-211238304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140355301 | chr2:211238305-211238306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560892581 | chr2:211238361-211238362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529828912 | chr2:211238566-211238567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546349161 | chr2:211238570-211238571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs57726246 | chr2:211238605-211238606 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs528557172 | chr2:211238606-211238607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551600141 | chr2:211238611-211238612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571601531 | chr2:211238619-211238620 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537470390 | chr2:211238637-211238638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112995517 | chr2:211238664-211238665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13404188 | chr2:211238678-211238679 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs557480838 | chr2:211238714-211238715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536958600 | chr2:211238786-211238787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553486597 | chr2:211238807-211238808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs377117032 | chr2:211238821-211238822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573381675 | chr2:211238880-211238881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61479752 | chr2:211238883-211238884 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs143689178 | chr2:211238922-211238923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574888605 | chr2:211238943-211238944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188555741 | chr2:211238957-211238958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62202075 | chr2:211239001-211239002 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs541638291 | chr2:211239023-211239024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113909045 | chr2:211239113-211239114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574343256 | chr2:211239149-211239150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540177732 | chr2:211239176-211239177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560261234 | chr2:211239209-211239210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62202076 | chr2:211239244-211239245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs545463144 | chr2:211239251-211239252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62202077 | chr2:211239260-211239261 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs530921631 | chr2:211239268-211239269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550956146 | chr2:211239274-211239275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567668055 | chr2:211239293-211239294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75521281 | chr2:211239312-211239313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547010560 | chr2:211239318-211239319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76036064 | chr2:211239353-211239354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62202078 | chr2:211239367-211239368 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs558608782 | chr2:211239375-211239376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200292632 | chr2:211239384-211239385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568571711 | chr2:211239408-211239409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:211223000-211242800 | Weak transcription | Psoas Muscle | Psoas |
2 | chr2:211235600-211242800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr2:211235800-211241000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
4 | chr2:211238000-211241000 | Weak transcription | HSMMtube | muscle |
5 | chr2:211241000-211241200 | Enhancers | HSMMtube | muscle |
6 | chr2:211241000-211242000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr2:211241000-211242000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr2:211241200-211241600 | Weak transcription | HSMMtube | muscle |
9 | chr2:211241600-211242200 | Enhancers | HSMMtube | muscle |
10 | chr2:211242600-211243000 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr2:211242800-211243000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr2:211242800-211243000 | Enhancers | Psoas Muscle | Psoas |
13 | chr2:211243000-211244000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr2:211244000-211244200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |